Washington, D.C. (February 5, 2015) — Pharmaceutical Research and Manufacturers of America (PhRMA) President and Chief Executive Officer, John Castellani, provided the following statement:
“PhRMA salutes the work of Commissioner Hamburg and recognizes her significant contributions to the thoughtful regulation of medicines, including science as a basis for better regulatory decisions. For nearly six years, and to the direct benefit of patients, Commissioner Hamburg has demonstrated strong leadership and an unwavering commitment to collaboration with all stakeholders.
“We look forward to working with the FDA’s leadership and Acting Commissioner Ostroff to bring safe and effective innovative medicines to patients.”
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. Since 2000, PhRMA member companies have invested more than $550 billion in the search for new treatments and cures, including an estimated $51.1 billion in 2013 alone.
Connect with PhRMA
For information on how innovative medicines save lives, please visit: